Monthly Archives: March 2009

Stem Cell, Public Policy & Innovation

Here’s an editorial from the American Enterprise Institute for Public Policy Research: Stem Cells and the Truth About Medical InnovationFirst few paragraphs… Whatever one thinks of the ethics of using human embryos in medical research, the rhetoric around President Barack … Continue reading

Posted in Uncategorized | Leave a comment

Cheaper Copies of Biotech Meds?

From Reuters: US lawmakers propose generic biotech drug plan U.S. lawmakers unveiled a bipartisan proposal on Wednesday to allow government approval for cheaper copies of biotechnology medicines that cost as much as tens of thousands of dollars per year. Representative … Continue reading

Posted in Uncategorized | Leave a comment

Biotech reverse merger: Fair to shareholders?

Biotech ethics isn’t all science ethics. This story is about fair treatment of shareholders. From the San Jose Mercury News: A biotech firm taking a chance on a reverse merger It is called a reverse merger. And for a failing … Continue reading

Posted in Uncategorized | 1 Comment

South African Law re Forensic Genetic Tests

Check this opinion piece, from the South African newspaper, The Times: Forensics bill raises ethics issues Proposed law is not strict enough when it comes to access to people‚Äôs genetic coding, leaving this open to exploitation and abuse, writes Mary … Continue reading

Posted in Uncategorized | Leave a comment

Top 30 Innovations of the Last 30 Years?

From Knowledge@Wharton: A World Transformed: What Are the Top 30 Innovations of the Last 30 Years? Is it possible to determine which 30 innovations have changed life most dramatically during the past 30 years? That is the question that Nightly … Continue reading

Posted in Uncategorized | Leave a comment

Clinic Won’t Offer ‘Designer Babies’ After All

From Fox News: After Criticism, Fertility Clinic Halts Delivery of Designer Babies The Fertility Institutes in Los Angeles, which last month said it would soon help couples select a baby’s gender and physical traits when undergoing a form of fertility … Continue reading

Posted in Uncategorized | Leave a comment

Overseas Clinical Trials: legal, regulatory, ethical and cultural questions

Here are two bioindustry lawyers, writing in Bioworld: What to Think About When Considering an Overseas Clinical Trial Program To remain competitive, drug, device and biotechnology companies must continually pursue innovative new products and product improvements. Clinical trials are essential … Continue reading

Posted in Uncategorized | 1 Comment